Dr. Kreher is a pediatric endocrinologist with more than 15 years of biotech industry experience in both Clinical Development and Medical Affairs. She has spent her career focused on drug development for patients with rare diseases in multiple therapeutic areas. Dr. Kreher is currently the Chief Medical Officer of Entrada Therapeutics where she is responsible for Clinical Development, Medical Affairs, Regulatory and Patient Advocacy. Her prior roles include Chief Medical Officer at Tiburio Therapeutics and Avrobio. Earlier in her career, she held roles of increasing responsibility at companies including Zafgen, Enobia (acquired by Alexion) and Genzyme. Dr. Kreher completed her pediatric endocrinology fellowship and pediatric residency at Riley Hospital for Children in Indianapolis, her M.D. at East Carolina University School of Medicine and her B.S. Biology from The University of North Carolina – Chapel Hill.
This person is not in the org chart
This person is not in any teams